This inventor holds 3 USPTO granted patents. Top assignees: University of California, Utah State University. Active years: 1993-1999.
Company Filing History:
Years Active: 1993-1999
Title: Innovations of Debra Arliene Feakes
Introduction
Debra Arliene Feakes is a notable inventor based in Los Angeles, CA (US). She has made significant contributions to the field of boron neutron capture therapy, holding a total of 3 patents. Her work focuses on innovative liposome compositions that enhance the effectiveness of cancer treatments.
Latest Patents
Feakes' latest patents include groundbreaking compositions for boron neutron capture therapy. One of her notable inventions involves liposome compositions that utilize X.sub.y B.sub.20 H.sub.17 L, where X represents an alkali metal, y ranges from 1 to 4, and L is a two-electron donor such as NH.sub.3. Additionally, she has developed methods that incorporate Na.sub.2 B.sub.10 H.sub.9 NCO and other borane salts, which can be used either free or encapsulated in liposomes. These liposomes may also contain embedded carboranes to increase the delivery of .sup.10 B and enhance tumor specificity.
Career Highlights
Throughout her career, Debra has worked with prestigious institutions such as the University of California and Utah State University. Her research has significantly advanced the understanding and application of boron neutron capture therapy in medical treatments.
Collaborations
Feakes has collaborated with esteemed colleagues, including Marion Frederick Hawthorne and Kenneth John Shelly. Their combined expertise has contributed to the development of innovative solutions in the field of cancer therapy.
Conclusion
Debra Arliene Feakes is a pioneering inventor whose work in boron neutron capture therapy has the potential to transform cancer treatment. Her innovative approaches and collaborations highlight her significant impact in the field.